Nick Damiano

CEO & Co-Founder

2023 - Current

Autonomous surgical robots with initial focus on urology YC S23

Venture Partner

2017

Y Combinator alumni venture fund Most active seed investor in the world as per Pitchbook

Founder & Advisor

2022 - 2023

CEO & Founder

2014 - 2022

Co-invented novel minimally invasive treatment for urinary obstruction related to BPH (enlarged prostate) Led company from concept through large randomized studies & market readiness Product has successfully treated > 300 patients in six countries Raised > $60M in venture, angel, debt, and grant funding Hired and led elite team of 28 FTEs First medtech company funded by Y Combinator (YC W15)

Chief Strategy Officer

2022 - 2023

A new & more powerful adult pluripotent stem cell platform for difficult-to-treat diseases

Co-Founder & Advisor

2014 - 2018

Company was acquired by Mendaera Formerly known as Nurep

Co-Founder & CTO

2012 - 2014

Initially known as Nurep, Inc. Mobile platform to help medical device companies remotely support surgical cases Built initial commercially launched product and closed first sale Company has raised > $100M in venture funding and launched in ~1000 hospitals

Biodesign Fellow Externship

2014 - 2014

Advised India-based medtech company on global commercialization strategy

Biodesign Innovation Fellow

2013 - 2014

Each year an international search brings a group of fellows to Biodesign with the talent and skillset to spark the creative process and innovate.

Entrepreneur

2013 - 2013

Blueprint Health is a Charter Member of the Global Accelerator Network, which was started by TechStars

Research Engineer

2008 - 2012

Developed key algorithms for world's first fully functional leadless pacemaker ASX: EBR